Erin Wright
Stock Analyst at Morgan Stanley
(4.55)
# 511
Out of 4,496 analysts
169
Total ratings
65.35%
Success rate
14.63%
Average return
Main Sectors:
38 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WBA Walgreens Boots Alliance | Maintains: Underweight | $13 → $9 | $11.01 | -18.26% | 6 | Jun 28, 2024 | |
| HUM Humana | Initiates: Equal-Weight | $374 | $387.38 | -3.45% | 1 | Jun 24, 2024 | |
| ELV Elevance Health | Initiates: Overweight | $643 | $500.12 | +28.57% | 1 | Jun 24, 2024 | |
| PDCO Patterson Companies | Maintains: Equal-Weight | n/a | $25.05 | - | 6 | Jun 20, 2024 | |
| PETS PetMed Express | Maintains: Underweight | $6.5 → $3.5 | $3.79 | -7.65% | 11 | Jun 12, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $620 → $596 | $468.20 | +27.30% | 10 | May 14, 2024 | |
| NVST Envista Holdings | Downgrades: Equal-Weight | $33 → $21 | $16.57 | +26.74% | 5 | Apr 26, 2024 | |
| ALGN Align Technology | Maintains: Overweight | $344 → $360 | $251.60 | +43.08% | 18 | Apr 25, 2024 | |
| MCK McKesson | Maintains: Overweight | $522 → $548 | $580.13 | -5.54% | 4 | Apr 15, 2024 | |
| CI Cigna | Reiterates: Overweight | $382 → $392 | $335.84 | +16.72% | 3 | Mar 4, 2024 | |
| ELAN Elanco Animal Health | Maintains: Overweight | $16 → $17 | $12.72 | +33.65% | 8 | Feb 27, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Overweight | $18 | $11.70 | +53.85% | 1 | Feb 20, 2024 | |
| HSIC Henry Schein | Maintains: Underweight | $69 → $65 | $70.34 | -7.59% | 4 | Nov 14, 2023 | |
| SONX Sonendo | Maintains: Equal-Weight | $5 → $4.6 | $0.07 | +6,266.78% | 6 | Nov 9, 2023 | |
| PAHC Phibro Animal Health | Maintains: Equal-Weight | $17 → $16 | $18.64 | -14.16% | 11 | Nov 9, 2023 | |
| XRAY DENTSPLY SIRONA | Maintains: Overweight | $43 → $39 | $26.36 | +47.95% | 11 | Nov 3, 2023 | |
| CVS CVS Health | Maintains: Overweight | $110 → $100 | $59.57 | +67.87% | 4 | Nov 2, 2023 | |
| CAH Cardinal Health | Maintains: Overweight | $92 → $100 | $95.03 | +5.23% | 5 | Aug 16, 2023 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $587 | $565.33 | +3.83% | 3 | Jul 14, 2023 | |
| ZTS Zoetis | Maintains: Overweight | $264 → $248 | $178.58 | +38.87% | 5 | Nov 15, 2022 | |
| LH Labcorp Holdings | Assumes: Overweight | $300 | $211.37 | +41.93% | 4 | Aug 22, 2022 | |
| DGX Quest Diagnostics | Assumes: Equal-Weight | $142 | $146.01 | -2.75% | 4 | Aug 22, 2022 | |
| AVTR Avantor | Maintains: Outperform | n/a | $20.85 | - | 2 | Jul 30, 2021 | |
| DHR Danaher | Maintains: Outperform | n/a | $243.54 | - | 4 | Jun 18, 2021 | |
| CNTG Centogene | Maintains: Outperform | n/a | $0.52 | - | 1 | Jun 17, 2021 | |
| CRL Charles River Laboratories International | Maintains: Neutral | n/a | $218.24 | - | 3 | May 28, 2021 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | n/a | $8.64 | - | 1 | Mar 3, 2021 | |
| LNTH Lantheus Holdings | Maintains: Neutral | n/a | $116.79 | - | 4 | Feb 26, 2021 | |
| MEDP Medpace Holdings | Maintains: Outperform | n/a | $421.31 | - | 5 | Feb 16, 2021 | |
| CHWY Chewy | Maintains: Outperform | n/a | $25.51 | - | 4 | Jan 13, 2021 | |
| TMO Thermo Fisher | Maintains: Outperform | n/a | $534.35 | - | 4 | Jan 12, 2021 | |
| CERT Certara | Initiates: Neutral | n/a | $16.08 | - | 1 | Jan 5, 2021 | |
| FLGT Fulgent Genetics | Maintains: Neutral | n/a | $21.82 | - | 4 | May 5, 2020 | |
| ICLR ICON PLC | Maintains: Outperform | n/a | $329.70 | - | 1 | Apr 23, 2020 | |
| IQV IQVIA Holdings | Maintains: Outperform | n/a | $224.57 | - | 1 | Apr 2, 2020 | |
| PINC Premier | Maintains: Outperform | n/a | $19.57 | - | 1 | May 9, 2018 | |
| OMI Owens & Minor | Maintains: Underperform | n/a | $14.82 | - | 1 | Nov 20, 2017 | |
| LMT Lockheed Martin | Maintains: Neutral | n/a | $474.92 | - | 1 | Oct 25, 2017 |
Walgreens Boots Alliance
Jun 28, 2024
Maintains: Underweight
Price Target: $13 → $9
Current: $11.01
Upside: -18.26%
Humana
Jun 24, 2024
Initiates: Equal-Weight
Price Target: $374
Current: $387.38
Upside: -3.45%
Elevance Health
Jun 24, 2024
Initiates: Overweight
Price Target: $643
Current: $500.12
Upside: +28.57%
Patterson Companies
Jun 20, 2024
Maintains: Equal-Weight
Price Target: n/a
Current: $25.05
Upside: -
PetMed Express
Jun 12, 2024
Maintains: Underweight
Price Target: $6.5 → $3.5
Current: $3.79
Upside: -7.65%
IDEXX Laboratories
May 14, 2024
Maintains: Overweight
Price Target: $620 → $596
Current: $468.20
Upside: +27.30%
Envista Holdings
Apr 26, 2024
Downgrades: Equal-Weight
Price Target: $33 → $21
Current: $16.57
Upside: +26.74%
Align Technology
Apr 25, 2024
Maintains: Overweight
Price Target: $344 → $360
Current: $251.60
Upside: +43.08%
McKesson
Apr 15, 2024
Maintains: Overweight
Price Target: $522 → $548
Current: $580.13
Upside: -5.54%
Cigna
Mar 4, 2024
Reiterates: Overweight
Price Target: $382 → $392
Current: $335.84
Upside: +16.72%
Elanco Animal Health
Feb 27, 2024
Maintains: Overweight
Price Target: $16 → $17
Current: $12.72
Upside: +33.65%
BrightSpring Health Services
Feb 20, 2024
Initiates: Overweight
Price Target: $18
Current: $11.70
Upside: +53.85%
Henry Schein
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $70.34
Upside: -7.59%
Sonendo
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $5 → $4.6
Current: $0.07
Upside: +6,266.78%
Phibro Animal Health
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $18.64
Upside: -14.16%
DENTSPLY SIRONA
Nov 3, 2023
Maintains: Overweight
Price Target: $43 → $39
Current: $26.36
Upside: +47.95%
CVS Health
Nov 2, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $59.57
Upside: +67.87%
Cardinal Health
Aug 16, 2023
Maintains: Overweight
Price Target: $92 → $100
Current: $95.03
Upside: +5.23%
UnitedHealth Group
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $565.33
Upside: +3.83%
Zoetis
Nov 15, 2022
Maintains: Overweight
Price Target: $264 → $248
Current: $178.58
Upside: +38.87%
Labcorp Holdings
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $211.37
Upside: +41.93%
Quest Diagnostics
Aug 22, 2022
Assumes: Equal-Weight
Price Target: $142
Current: $146.01
Upside: -2.75%
Avantor
Jul 30, 2021
Maintains: Outperform
Price Target: n/a
Current: $20.85
Upside: -
Danaher
Jun 18, 2021
Maintains: Outperform
Price Target: n/a
Current: $243.54
Upside: -
Centogene
Jun 17, 2021
Maintains: Outperform
Price Target: n/a
Current: $0.52
Upside: -
Charles River Laboratories International
May 28, 2021
Maintains: Neutral
Price Target: n/a
Current: $218.24
Upside: -
Maravai LifeSciences Holdings
Mar 3, 2021
Maintains: Outperform
Price Target: n/a
Current: $8.64
Upside: -
Lantheus Holdings
Feb 26, 2021
Maintains: Neutral
Price Target: n/a
Current: $116.79
Upside: -
Medpace Holdings
Feb 16, 2021
Maintains: Outperform
Price Target: n/a
Current: $421.31
Upside: -
Chewy
Jan 13, 2021
Maintains: Outperform
Price Target: n/a
Current: $25.51
Upside: -
Thermo Fisher
Jan 12, 2021
Maintains: Outperform
Price Target: n/a
Current: $534.35
Upside: -
Certara
Jan 5, 2021
Initiates: Neutral
Price Target: n/a
Current: $16.08
Upside: -
Fulgent Genetics
May 5, 2020
Maintains: Neutral
Price Target: n/a
Current: $21.82
Upside: -
ICON PLC
Apr 23, 2020
Maintains: Outperform
Price Target: n/a
Current: $329.70
Upside: -
IQVIA Holdings
Apr 2, 2020
Maintains: Outperform
Price Target: n/a
Current: $224.57
Upside: -
Premier
May 9, 2018
Maintains: Outperform
Price Target: n/a
Current: $19.57
Upside: -
Owens & Minor
Nov 20, 2017
Maintains: Underperform
Price Target: n/a
Current: $14.82
Upside: -
Lockheed Martin
Oct 25, 2017
Maintains: Neutral
Price Target: n/a
Current: $474.92
Upside: -